Promising Advances in Vaccines and Signs for Pancreatic Cancer
A non-personalized off-the-shelf vaccine called ELI-002 2P shows promise in preventing the return of pancreatic and colorectal cancers by training the immune system to target specific mutations, with early results indicating longer survival for responders, though further research is needed.